Table 2 Application results of the SIC method to pharmaceutical formulations
Formulation | Manufacturer | Content (mg) | Recovery | ||
|---|---|---|---|---|---|
| Â | Â | HTZ | PRP | HTZ | PRP |
Inderide® tablets | Wyeth Pharmaceuticals Inc. (Philadelphia, PA, US) | 25 | 40 | 100.5 | 93.8 |
Inderide® tablets | Wyeth Pharmaceuticals Inc., (Philadelphia, PA, US) | 25 | 80 | 97.0 | 104.9 |
Ciplar LA® tablets | Cipla Ltd. Mumbai Central (Mumbai, India) | - | 40 | - | 93.9 |
Lannett® tablets | Lannett Company Inc. (Philadelphia, PA, US) | 25 | - | 100.3 | - |